We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Alliance to Develop Biologic Detection Systems

By HospiMedica staff writers
Posted on 20 Aug 2001
A collaboration to develop and design biologic-detection systems for military and other preparedness applications has been announced by Environmental Technologies Group Inc. (ETG, Baltimore, MD, USA) and Cepheid (Sunnyvale, CA, USA). Under the agreement, the two companies will develop systems based on Cepheid's proprietary technologies for the capture, purification, amplification, and detection of DNA.

Cepheid will provide subsystems and sub-assemblies to ETG for integration into, and manufacture of, fully automated bio-detection systems that will range from hand-held units to stationary monitoring systems for use in a variety of military and civilian settings. Cepheid's I-Core and microfluidic technologies will be key components of the DNA detection systems that will be made and marketed on a worldwide basis by ETG and its sister company, Graseby Dynamics Limited, under royalty-bearing licenses from Cepheid. ETG, a part of Smiths Aerospace (London, UK), is a leading provider of full-service, advanced engineering technology for nuclear, biologic, and chemical detection systems.

"ETG is the ideal partner to adapt Cepheid's versatile DNA testing technology to the bio-defense market, and together we are committed to developing systems that deliver faster, more sensitive results under any conditions,” said Tom Gutshall, chairman and CEO of Cepheid.




Related Links:
Cepheid
Graseby Dynamics

Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Repetitive Pipette
VWR® Stepper Pro
Automated Clinical Chemistry Analyzer
Envoy 500+

Latest Industry News

Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases
20 Aug 2001  |   Industry

Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal
20 Aug 2001  |   Industry

Bruker Expands NGS Capabilities for Sepsis and Bloodstream Infections
20 Aug 2001  |   Industry



PURITAN MEDICAL